Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

First patient in treatment in RhoVac's clinical phase IIb study in United Kingdom

prnasiaJanuary 08, 2021

Tag: RhoVac AB , RhoVac-002 , cancer

PharmaSources Customer Service